MoneyWorks4Me

Dr Reddys Laboratories board recommends final dividend

12 May 2016 Evaluate

Dr Reddys Laboratories has informed that the Board of Directors of the Company at its meeting held on May 12, 2016, has recommended a final dividend of Rs 20 (400%) per equity share of Rs 5 face value, for the financial year 2015-16. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited / dispatched on or after August 1, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..